PDS Biotechnology (PDSB) Tops Q2 EPS by 10c

PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.23), $0.10 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Barclays on Rivian (RIVN) into earnings: 'Autonomy remains show me'
• Citi Reiterates Buy Rating on Estee Lauder (EL), Adding Upside 90-Day Catalyst Watch
• salesforce.com (CRM) PT Lowered to $250 at Evercore ISI